Correlation Between Morgan Stanley and Arch Biopartners
Can any of the company-specific risk be diversified away by investing in both Morgan Stanley and Arch Biopartners at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Morgan Stanley and Arch Biopartners into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Morgan Stanley Direct and Arch Biopartners, you can compare the effects of market volatilities on Morgan Stanley and Arch Biopartners and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Morgan Stanley with a short position of Arch Biopartners. Check out your portfolio center. Please also check ongoing floating volatility patterns of Morgan Stanley and Arch Biopartners.
Diversification Opportunities for Morgan Stanley and Arch Biopartners
0.14 | Correlation Coefficient |
Average diversification
The 3 months correlation between Morgan and Arch is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding Morgan Stanley Direct and Arch Biopartners in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arch Biopartners and Morgan Stanley is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Morgan Stanley Direct are associated (or correlated) with Arch Biopartners. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arch Biopartners has no effect on the direction of Morgan Stanley i.e., Morgan Stanley and Arch Biopartners go up and down completely randomly.
Pair Corralation between Morgan Stanley and Arch Biopartners
Given the investment horizon of 90 days Morgan Stanley Direct is expected to generate 0.42 times more return on investment than Arch Biopartners. However, Morgan Stanley Direct is 2.36 times less risky than Arch Biopartners. It trades about 0.15 of its potential returns per unit of risk. Arch Biopartners is currently generating about -0.09 per unit of risk. If you would invest 1,946 in Morgan Stanley Direct on September 23, 2024 and sell it today you would earn a total of 138.00 from holding Morgan Stanley Direct or generate 7.09% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 97.73% |
Values | Daily Returns |
Morgan Stanley Direct vs. Arch Biopartners
Performance |
Timeline |
Morgan Stanley Direct |
Arch Biopartners |
Morgan Stanley and Arch Biopartners Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Morgan Stanley and Arch Biopartners
The main advantage of trading using opposite Morgan Stanley and Arch Biopartners positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Morgan Stanley position performs unexpectedly, Arch Biopartners can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arch Biopartners will offset losses from the drop in Arch Biopartners' long position.Morgan Stanley vs. United Rentals | Morgan Stanley vs. HE Equipment Services | Morgan Stanley vs. Triton International Limited | Morgan Stanley vs. Ryanair Holdings PLC |
Arch Biopartners vs. Aptose Biosciences | Arch Biopartners vs. iShares Canadian HYBrid | Arch Biopartners vs. Altagas Cum Red | Arch Biopartners vs. European Residential Real |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Complementary Tools
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
CEOs Directory Screen CEOs from public companies around the world |